Bing

SEARCH HISTORY

The stock has a consensus rating of “Hold” and a consensus price target of $6.00. Shares of Amarin Co. plc (NASDAQ:AMRN) opened at 2.46 on Wednesday. Amarin Co. plc has a 52 week low of $0.78 and a 52 week high of $3.33. The stock’s …
Ticker Report · 29 minutes ago
Short Interest
Shares of Amarin Co. plc (NASDAQ:AMRN) opened at 2.46 on Wednesday. Amarin Co. plc has a one year low of $0.78 and a one year high of $3.33. The stock’s 50-day moving average is $2.25 and its 200-day moving average is $1.82. The company’s …
sleekmoney.com · 3 minutes ago
Biotech stock Amarin Corporation plc (ADR) (NASDAQ:AMRN) has been quite the conversation piece lately, and for good reason. Following a major analyst upgrade from HC Wainwright a couple weeks ago, we saw tremendous gains in Amarin stock
Investor Place · 3/23/2015
More from Bing News
I believe the stock has significant upside potential. http://seekingalpha.com/article/2586135-amarins-value-with-or-without-reduce-it... I have been hearing that there could be a huge IR campaign taking off for AMRN in the near future. I have been holding ...
Stockhouse · 6/23/2015
Amarin Corporation plc (AMRN) shares are up more than 14% to $2.72 in early trading. The move comes on a big volume too with the issue currently trading more than 13.6 million shares, compared to the average volume of 4.4 million shares. The stock
Wall Street Pit · 3/18/2015
Amarin Corporation plc (AMRN - Snapshot Report) was a big mover last session ... This breaks the recent trend of the company as the stock is now trading above the volatile price range of $1.85–$2.07 in the past one-month time frame.
ZACKS · 5/29/2015
Amarin Co. plc (NASDAQ:AMRN)‘s stock had its “sector perform” rating restated by equities researchers at Oppenheimer in a research report issued on Tuesday. Amarin Co. plc (NASDAQ:AMRN) opened at 2.30 on Tuesday. Amarin Co. plc has a …
Mideast Times · 6/3/2015
Click to get this free report AMARIN CORP PLC (AMRN): Free Stock Analysis Report ACTELION LTD (ALIOF): Free Stock Analysis Report To read this article on Zacks.com click here. Personal Investing Ideas & Strategies Finance Trading
Yahoo Finance · 5/29/2015
Investors in Amarin Corp plc (NASD: AMRN) saw new options begin trading today, for the September 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the new September 27th contracts …
Forbes · 9/19/2013
Amarin Corporation plc ( AMRN) was a big mover last session ... This breaks the recent trend of the company as the stock is now trading above the volatile price range of $1.85-$2.07 in the past one-month time frame. This med-biomed/gene stock witnessed ...
NASDAQ · 5/29/2015

Amarin Corporation

Company
Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets me…
Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Amarin develops the drug Vascepa which is a prescription grade omega-3 fatty acid. In December 2007, the company acquired Ester Neurosciences Limited for 8.1 million USD. Amarin CEO Joe Zakrzewski has said that the company would like to first work on building its infrastructure out to commercialize the drug in the United States. Recently on July 26, 2012, their lead-candidate drug named Vascepa received FDA-approval. Vascepa will also be a key competitor against GlaxoSmithKline's Lovaza.
Data from: Wikipedia